Global Paclitaxel Market Analysis 2015-2019 and Forecast 2020-2025

ReportPage
Report ID
62727
Published Date
15-Jan
No of Report Page
88
Report Category
Medical Devices
Editor's Rating
US $5,960.00
US $5,960.00
US $2,980.00

  • Report Details

    Snapshot
    Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it “taxol”.Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and solub

    More...
  • Table Of Content

    Table of Content

    1 Industry Overview
    1.1 Paclitaxel Industry
    Figure Paclitaxel Industry Chain Structure
    1.1.1 Overview
    1.1.2 Development of Paclitaxel
    1.2 Market Segment
    1.2.1 Upstream
    Table Upstream Segment of Paclitaxel
    1.2.2 Downstream
    Table Application Segment of Paclitaxel
    Table Global Pac

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample